LiveSpo's International Public
LiveSpo CLAUSY’s report on Nature.com. (2024)
Dang, H.T., Tran, D.M., Phung, T.T.B. et al. Promising clinical and immunological efficacy of Bacillus clausii spore probiotics for supportive treatment of persistent diarrhea in children. Sci Rep 14, 6422 (2024). https://doi.org/10.1038/s41598-024-56627-9
LiveSpo's report on BRILL. (2023)
Nguyen, T.T., Bui, A.T.P., Le, N.T.H., Vo, H.T.N., Nguyen, A.H., Pham, T.D., Hara, T., Yokota, K., Matsutani, M., Takatsuka, Y., & Nguyen, A.T.V. (2023). Heat-stable spores of carotenoid-producing Bacillus marisflavi and non-pigmented Bacillus subtilis cooperatively promote growth, quality, and gut microbiota of white-leg shrimp. Beneficial Microbes (published online ahead of print 2023). https://doi.org/10.1163/18762891-20230041
LiveSpo NAVAX’s report on Nature.com. (2023)
LiveSpo NAVAX’s report on Nature.com. (2022)
Dien Minh Tran, Tu Thanh Tran, Thuy Thi Bich Phung, Huyen Thi Bui, Phuc Thanh Thi Nguyen, Tam Thi Vu, Nga Thi Phuong Ngo, Mai Thi Nguyen, Anh Hoa Nguyen & Anh Thi Van Nguyen (2022); Nasal-spraying Bacillus spores as an effective sympyomatic treatment for children with acute respiratory syncytial virus infection; Scientific Reports (2022) 12:12402, DOI: 10.1038/s41598-022-16136-z.
FDA NDI 1167 for LiveSpo COLON.
Bacillus clausii and Bacillus subtilis, under tradename LiveSpo® COLON – Ana Bio Research & Development JSC – 10/15/2020. Letter from FDA CFSAN to Ana Bio Research & Development JSC regarding NDI 1167 – LiveSpo COLON
LiveSpo NAVAX on the ClinicalTrials.gov - U.S. National Library of Medicine.
Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children.
LiveSpo DIA30 on the ClinicalTrials.gov - U.S. National Library of Medicine.
Effects of Probiotic in Treatment of Persistent Diarrhea in Children.
LiveSpo X-Secret on the ClinicalTrials.gov - U.S. National Library of Medicine.
Effects of LiveSpo X-secret in Supporting Treatment of Sexually Transmitted Diseases.